I like TARA and ABUS, although ABUS is pivoting to being a patent troll (which I agree with and have paired with ROIV). Truly have to investigate what management is doing, as you illustrated.
I like TARA and ABUS, although ABUS is pivoting to being a patent troll (which I agree with and have paired with ROIV). Truly have to investigate what management is doing, as you illustrated.
My understanding is that ABUS are going to cut costs, sell off their remaining assets (HEP B program, if I recall) & exclusively be a shell w/ a claim on the litigation of intellectual property claim against MRNA & PFE. Worth reading the last few K's.
I like TARA and ABUS, although ABUS is pivoting to being a patent troll (which I agree with and have paired with ROIV). Truly have to investigate what management is doing, as you illustrated.
My understanding is that ABUS are going to cut costs, sell off their remaining assets (HEP B program, if I recall) & exclusively be a shell w/ a claim on the litigation of intellectual property claim against MRNA & PFE. Worth reading the last few K's.